HOME >> BIOLOGY >> NEWS
Study fails to verify gene variations as risk factors for certain cardiovascular problems

New research has failed to confirm findings from smaller studies that 85 gene variations are associated with an increased risk for acute coronary syndromes (ACS), which includes heart attack and a type of angina, according to a study in the April 11 issue of JAMA.

Previous studies have identified a number of genetic variations as potential cardiovascular risk factors, but few, if any, have been established definitively. "Before use in clinical care, potential genetic risk factors would ideally be replicated en masse in large, well-characterized patient populations. To date, no such comprehensive validation of genetic variants potentially associated with ACS or atherosclerosis has been reported," the authors write.

Thomas M. Morgan M.D., formerly of the Yale University School of Medicine, New Haven, Conn., and colleagues conducted a study to validate genetic risk factors for ACS. The researchers identified genetic variants previously reported as significant susceptibility factors for atherosclerosis or ACS through a literature search of published articles. This study included 811 patients with ACS and 650 age- and sex-matched controls who were genotyped for 85 variants in 70 genes and attempted to replicate previously reported associations.

Of 85 variants tested, only one of the gene variants was nominally statistically significant. Only four additional genes were positive in model-free analysis. Neither number of associations was more frequent than expected by chance, given the number of comparisons. Only 41 of 84 predefined risk variants were even marginally more frequent in cases than in controls (with 1 tie).

"We were unable to confirm as risk factors for ACS 85 genetic variants because none were unequivocally validated in this large case-control study of 1,461 participants," the authors write. "We therefore conclude that our findings, in this large sample of well-characterized ACS patients and controls, cannot support
'"/>

Contact: Diane Duke Williams
314-286-0111
JAMA and Archives Journals
10-Apr-2007


Page: 1 2

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study points to new way to predict death risk from torn aorta
6. Study identifies new gene therapy tools for inherited blindness
7. Study finds contaminated water reaching Floridas offshore keys
8. Study sheds light on why humans walk on two legs
9. Study explains how pathogens evolve to escape detection
10. Study finds hereditary link to premenstrual depression
11. Study identifies energy efficiency as reason for evolution of upright walking

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2020)... ... 2020 , ... Join experts from Envigo Lauren Klaskala, Project Manager ... webinar on Wednesday, July 8, 2020 at 11am EDT (4pm BST/UK). , Nuclease-based ... models. However, while modifying the genome may be more straightforward, the challenge to create ...
(Date:6/5/2020)... ... ... Murrieta Genomics has announced that its wholly owned subsidiary, ... Next Generation Genomic Sequencing (NGS) . This is the third application filed by ... , “I have been at the bench for over 20 years,” stated Brandon Young, ...
(Date:5/30/2020)... SAN JOSE, Calif. (PRWEB) , ... May 29, ... ... services and enabler of digital transformation for enterprises globally, has collaborated with EchoNous ... by the FDA. It can measure systolic heart function, which has been ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... BOSTON (PRWEB) , ... July 06, 2020 , ... ... Innovative Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of ... Since 2003, Bio-IT World has hosted an elite awards program, highlighting outstanding examples ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading provider ... for businesses of all types to ensure cleanliness, distancing and occupancy with its patent ... Safe Space™ enabled business will provide a health performance index system that scores all ...
(Date:6/23/2020)... ... 2020 , ... Kerafast Inc. , developers of an ... availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed ... viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment. ...
(Date:6/23/2020)... PORTLAND, Ore. (PRWEB) , ... June 23, 2020 ... ... advancement of innovative CNS therapies, today announced that it has filed an Investigational ... initiate a Phase 2b clinical trial of its lead drug candidate NBTX-001 in ...
Breaking Biology Technology:
Cached News: